In May 2018, the Innovate Indiana Fund invested $200,000 in Costello, a sales co-pilot software company. Only a year and a half later, Costello was acquired by Atlanta-based sales engagement platform SalesLoft...
In November, we celebrate National Entrepreneurship Month. It’s good that we do, too, because entrepreneurs deserve all the support and encouragement they receive. Whether they are women, men or youngsters; whether their work is high-tech, low-tech or no tech; whether they are urban or rural...
Jacob Babcock, an IU Bloomington alumnus, is CEO of NuCurrent. The company provides wireless power solutions to Fortune 1000 companies and other innovation leaders...
Reuben Vandeventer, an IU Bloomington alumnus, is co-founder of S2 Data Risk. The company enables businesses to account for data risk and safeguard against unintended consequences that accompany the digital economy...
Dr. Kathleen T. Unroe, associate professor of medicine at the IU School of Medicine, is founder of Care Revolution Inc. The company’s model is a rigorously tested RN-based program that fits into any nursing home operation, designed to enhance patient care in place and reduce...
Congratulations to Jason Whitney, IU Ventures associate vice president and IU Angel Network executive director. He has joined the board of directors at Dimension Mill, the 19,000-square-foot coworking space and business incubator in downtown Bloomington...
IU Ventures has invested $250,000 in Qumulex, a company poised to transform the video surveillance and access control industry by unifying video surveillance and access control with cloud storage and accessibility...
Announcing our first exit and two new investments in Q3 2019:
In August, IU Philanthropic Venture Fund (IUPhV) portfolio company Doxly was acquired by Chicago-based Litera Microsystems. IUPhV invested $250,000 on November 30, 2018. All equity realizations from IUPhV investments are rolled back into the fund for reinvestment, so...
Mark R. Kelley, the Betty and Earl Herr Professor of Pediatric Oncology Research at the IU School of Medicine, is chief scientific officer at Apexian Pharmaceuticals. Apexian is a clinical-stage company looking for safe and effective therapies...